Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Acquisition

25 Jul 2017 07:00

RNS Number : 9826L
Compagnie de Saint-Gobain
25 July 2017
 

PRESS RELEASE

 

July 25, 2017

 

Saint-Gobain acquires TekBond,

adhesives specialist in Brazil

 

 

 

Saint-Gobain has signed a share purchase agreement to acquire 100% of the equity capital of TekBond, the number two adhesives business in Brazil operating in the construction sector and on the automotive aftermarket.

 

TekBond supplies a broad range of adhesives, sealants, sprays and masking tapes all over Brazil. Its offer is based on a detailed knowledge of the market and customers to adjust its product formulations to local specificities.

 

TekBond will join the High-Performance Materials Activity. This acquisition will enable Saint-Gobain in Brazil to create important synergies with the Abrasives, Mortars and Flat Glass business lines on the construction and industrial markets.

 

The deal is subject to the approval of the Brazilian antitrust authorities.

 

 

 

ABOUT SAINT-GOBAIN

Saint-Gobain designs, manufactures and distributes materials and solutions which are key ingredients in the wellbeing of each of us and the future of all. They can be found everywhere in our living places and our daily life: in buildings, transportation, infrastructure and in many industrial applications. They provide comfort, performance and safety while addressing the challenges of sustainable construction, resource efficiency and climate change.

 

€39.1 billion in sales in 2016

Operates in 67 countries

More than 170,000 employees

www.saint-gobain.com @saintgobain

 

 

Analyst/Investor relations

 

 

Media relations

Vivien Dardel

Florent Nouveau

Floriana Michalowska

 +33 1 47 62 44 29

 +33 1 47 62 30 93

 +33 1 47 62 35 98

 

Susanne Trabitzsch

 

 +33 1 47 62 43 25

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQRAMATMBATMFR
Date   Source Headline
11th Jan 20197:06 amRNSNew facility
10th Jan 20195:42 pmRNSDisposal
8th Jan 20197:12 amRNSDisposal
18th Dec 20188:48 amRNSAcquisition
30th Nov 20189:24 amRNSCancellation of shares
26th Nov 20188:21 amRNSLaunching of Transformation Program
23rd Nov 20188:23 amRNSDisposal
25th Oct 20185:02 pmRNS3rd Quarter Results
11th Oct 20183:57 pmRNSFinal Terms
10th Oct 20185:49 pmRNSFinal terms
5th Oct 20187:47 amRNSAcquisition
1st Oct 201810:43 amRNSStabilisation Notice - Compagnie de Saint-Gobain
20th Sep 20185:10 pmRNSAcquisition
20th Sep 20184:57 pmRNSFinal Terms
20th Sep 20184:56 pmRNSFinal Terms
12th Sep 20186:15 pmRNSStabilisation Notice - COMPAGNIE DE SAINT-GOBAIN
12th Sep 20185:49 pmRNSIssue of Debt
12th Sep 20188:54 amRNSStabilisation Notice - COMPAGNIE DE SAINT-GOBAIN
24th Aug 20185:21 pmRNSProspectus Supplement
1st Aug 20187:11 amRNSAcquisition
31st Jul 20185:23 pmRNSDivestment
26th Jul 20185:15 pmRNSHalf-year Report
13th Jul 20185:15 pmRNSProspectus
3rd Jul 20189:35 amRNSAcquisition
22nd Jun 20182:34 pmRNSFinal Terms
22nd Jun 20182:33 pmRNSFinal Terms
15th Jun 20188:47 amRNSCancelation of shares
24th May 20182:24 pmRNSFinal Terms
11th May 20187:00 amRNSAcquisition
26th Apr 20184:52 pmRNS1st Quarter Results
17th Apr 20184:58 pmRNSFinal Terms
13th Apr 20187:16 amRNSAcquisition
11th Apr 20185:08 pmRNSAcquisition
28th Mar 20185:02 pmRNSCapex
22nd Mar 20183:14 pmRNSIssue of Debt
19th Mar 20189:04 amRNSAcquisition
13th Mar 20184:57 pmRNSIssue of Debt
2nd Mar 20187:00 amRNSProspectus Supplement
1st Mar 20184:53 pmRNSAcquisition
22nd Feb 20185:04 pmRNS2017 Results
25th Jan 20184:52 pmRNSNew capacity
11th Jan 20185:12 pmRNSAcquisition
20th Dec 20174:50 pmRNSIssue of Debt
19th Dec 20177:27 amRNSAcquisition
6th Dec 20174:49 pmRNSAcquisition
4th Dec 20177:04 amRNSAcquisition
30th Nov 20174:55 pmRNSShares cancellation
24th Nov 20174:51 pmRNSAcquisition
23rd Nov 20176:12 pmRNSDecisions of Board of Directors
26th Oct 20176:08 pmRNSNine-months sales

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.